About My Health Careers Internship MedBlogs Contact us

Simple Blood Test can Improve Evaluation of Cystic Fibrosis Patients

by VR Sreeraman on October 26, 2008 at 11:07 AM
Font : A-A+

 Simple Blood Test can Improve Evaluation of Cystic Fibrosis Patients

National Jewish Health researchers have come up with a simple blood test that can measure cystic fibrosis patients' response to therapy more accurately and quickly than current tests.

Writing about the new blood test in the American Journal of Respiratory and Critical Care Medicine, the researchers describe it as a measure of inflammatory gene expression.


They hope that the test can improve patient care, and help clear a backlog of promising medications now hung up in clinical trials.

"The currently accepted test, a measure of a patients' ability to exhale air, has several limitations that make it ineffective for some patients and not sensitive enough for clinical trials of many new medications," said Dr. Milene Saavedra, lead author of the study and Assistant Professor of Medicine at National Jewish Health.

"By measuring the activity of genes associated with the immune/inflammatory response, we can get a more accurate picture of the biological processes occurring inside the lungs," the researcher added.

Currently, response to medication is measured by how much air a person can rapidly exhale: forced expiratory volume in one second (FEV1).

Patients' FEV1 generally improves when inflammation is reduced, but not all patients' FEV1 improves significantly, and changes can take weeks to months to show up.

The researchers say that they have identified three genes that most accurately correlated with a positive therapeutic response, namely CD36, CD64, and ADAM9.

While CD36 and CD64 are genes associated with cells' absorption of foreign organisms and cellular debris, according to them, ADAM9 is associated with tissue destruction that allows inflammatory cells to move through tissue.

"The expression of these genes correlated with FEV1, other inflammatory markers, and various clinical factors," said co-author Dr. Jerry Nick , Associate Professor of Medicine at National Jewish.

"When combined with FEV1, they offered a more accurate and sensitive measure of response to therapy than either alone. We believe they could be extremely useful in clinical care of patients and trials of new CF therapies," Dr. Nick added.

The researchers are now conducting a trial of 60 CF patients to provide stronger statistical evidence for the power of CD36, CD64 and ADAM9 to diagnose a positive response to therapy by CF patients.

Source: ANI

News A-Z
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Thalassemia Genetic Testing of Diseases Cystic Fibrosis Blood in Stools - Symptom Evaluation Bombay Blood Group Fibroscan for Fatty Liver Cirrhosis and Fibrosis Retroperitoneal Fibrosis / Ormondīs Disease 

Recommended Reading
Birth Defects - Genetic - Cystic Fibrosis
Cystic fibrosis is a progressively debilitating genetic disorder, which mainly affects the lungs ......
Glow in the Dark Cat to Treat Cystic Fibrosis Created
Scientists in New Orleans have created a cat that may look like a normal tabby in light but glows .....
Hope for Cystic Fibrosis Cure in Near Future
Researchers from the University of Calgary have suggested a new approach that may help in treating ....
Blood in Stools - Symptom Evaluation
Blood in stools results from bleeding that arises from any part of the digestive tract. Causes of bl...
Bombay Blood Group
Bombay blood group is a rare blood type in which the people have an H antigen deficiency. They can r...
Cystic Fibrosis
Cystic fibrosis is a genetic disease involving the mucus and sweat glands and the medical world has ...
Fibroscan for Fatty Liver Cirrhosis and Fibrosis
Recently, Fibroscan has incorporated the noninvasive Controlled Attenuation Parameter technique to e...
Genetic Testing of Diseases
Genetic testing helps to confirm a genetic condition in an individual and involves q complex laborat...
Retroperitoneal Fibrosis / Ormondīs Disease
Retroperitoneal fibrosis or Ormond's disease a rare disorder occurs when extra fibrous tissue forms ...
Thalassemia is an inherited blood disorder passed on through parental genes causing the body to prod...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use